Catalyst Pharmaceuticals, Inc. (CPRX)
NASDAQ: CPRX · Real-Time Price · USD
24.79
+0.55 (2.27%)
At close: Mar 9, 2026, 4:00 PM EDT
24.00
-0.79 (-3.19%)
After-hours: Mar 9, 2026, 7:56 PM EDT
Catalyst Pharmaceuticals Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | 709.17 | 517.55 | 137.64 | 298.4 | 171.45 | Upgrade
|
| Short-Term Investments | - | - | - | - | 19.82 | Upgrade
|
| Cash & Short-Term Investments | 709.17 | 517.55 | 137.64 | 298.4 | 191.27 | Upgrade
|
| Cash Growth | 37.02% | 276.03% | -53.87% | 56.01% | 36.35% | Upgrade
|
| Accounts Receivable | 126.48 | 65.48 | 53.65 | 10.79 | 6.72 | Upgrade
|
| Other Receivables | 1.79 | 0.54 | - | - | - | Upgrade
|
| Receivables | 128.27 | 66.01 | 53.65 | 10.79 | 6.72 | Upgrade
|
| Inventory | 37.17 | 19.54 | 15.64 | 6.81 | 7.87 | Upgrade
|
| Prepaid Expenses | 17.39 | 20 | 12.05 | 4.32 | 3.92 | Upgrade
|
| Other Current Assets | 2.04 | 0.51 | 0.35 | 0.49 | 0.33 | Upgrade
|
| Total Current Assets | 894.03 | 623.61 | 219.33 | 320.81 | 210.11 | Upgrade
|
| Property, Plant & Equipment | 2.97 | 3.58 | 3.7 | 3.62 | 3.98 | Upgrade
|
| Long-Term Investments | 22.54 | 21.56 | 16.49 | - | - | Upgrade
|
| Other Intangible Assets | 131.67 | 156.67 | 194.05 | 32.47 | - | Upgrade
|
| Long-Term Deferred Tax Assets | 52.77 | 45.98 | 36.54 | 18.74 | 23.7 | Upgrade
|
| Other Long-Term Assets | - | - | - | - | 0.01 | Upgrade
|
| Total Assets | 1,104 | 851.41 | 470.11 | 375.63 | 237.79 | Upgrade
|
| Accounts Payable | 11.2 | 16.59 | 14.8 | 3.98 | 2.77 | Upgrade
|
| Accrued Expenses | 61.66 | 53.85 | 40.29 | 27.83 | 21.95 | Upgrade
|
| Current Portion of Leases | 0.44 | 0.4 | 0.37 | 0.34 | 0.31 | Upgrade
|
| Current Income Taxes Payable | 1.4 | 0.89 | 0.73 | 8.7 | 0.08 | Upgrade
|
| Other Current Liabilities | 72.46 | 48.94 | 19.88 | 16.75 | 1.96 | Upgrade
|
| Total Current Liabilities | 147.15 | 120.68 | 76.06 | 57.59 | 27.06 | Upgrade
|
| Long-Term Leases | 2.35 | 2.79 | 3.19 | 3.56 | 3.89 | Upgrade
|
| Other Long-Term Liabilities | 0.21 | 0.32 | 2.98 | 14.06 | - | Upgrade
|
| Total Liabilities | 149.71 | 123.78 | 82.23 | 75.21 | 30.96 | Upgrade
|
| Common Stock | 0.12 | 0.12 | 0.11 | 0.11 | 0.1 | Upgrade
|
| Additional Paid-In Capital | 479.96 | 442.29 | 266.49 | 250.43 | 233.19 | Upgrade
|
| Retained Earnings | 474.19 | 285.16 | 121.27 | 49.86 | -26.31 | Upgrade
|
| Comprehensive Income & Other | - | 0.06 | 0.01 | 0.02 | -0.15 | Upgrade
|
| Shareholders' Equity | 954.27 | 727.63 | 387.88 | 300.42 | 206.83 | Upgrade
|
| Total Liabilities & Equity | 1,104 | 851.41 | 470.11 | 375.63 | 237.79 | Upgrade
|
| Total Debt | 2.79 | 3.19 | 3.56 | 3.89 | 4.2 | Upgrade
|
| Net Cash (Debt) | 706.38 | 514.37 | 134.08 | 294.5 | 187.06 | Upgrade
|
| Net Cash Growth | 37.33% | 283.63% | -54.47% | 57.43% | 33.38% | Upgrade
|
| Net Cash Per Share | 5.55 | 4.12 | 1.18 | 2.64 | 1.74 | Upgrade
|
| Filing Date Shares Outstanding | 122.12 | 121.45 | 117.86 | 105.65 | 102.74 | Upgrade
|
| Total Common Shares Outstanding | 122.51 | 120.88 | 107.12 | 105.26 | 102.99 | Upgrade
|
| Working Capital | 746.88 | 502.93 | 143.27 | 263.22 | 183.04 | Upgrade
|
| Book Value Per Share | 7.79 | 6.02 | 3.62 | 2.85 | 2.01 | Upgrade
|
| Tangible Book Value | 822.59 | 570.96 | 193.83 | 267.95 | 206.83 | Upgrade
|
| Tangible Book Value Per Share | 6.71 | 4.72 | 1.81 | 2.55 | 2.01 | Upgrade
|
| Machinery | 1.11 | 1.05 | 0.49 | 0.27 | 0.25 | Upgrade
|
| Leasehold Improvements | 0.99 | 0.99 | 0.99 | 0.98 | 0.98 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.